STAB VIDA

What STAB VIDA does

STAB VIDA, Lda. is a Portuguese biotechnology SME founded in 2001 and headquartered at Madan Parque on the FCT/UNL campus in Caparica, Portugal. The company operates ISO 9001:2015- and ISO 13485:2018-certified DNA and Human Genetics laboratories providing a broad portfolio of genetic testing services: Sanger sequencing (ABI 3130 / 3730xl), Next Generation Sequencing on Ion Torrent and Illumina HiSeq 2500 / MiSeq platforms, capillary electrophoresis fragment analysis, oligonucleotide and PCR reagent manufacturing (Surf Taq, Surf Hot Taq, Surf Red Taq, Surf Long Taq, Surf PFU, Surf Titan variants), clinical sequencing, paternity testing (24 STR markers, 99.9999% confidence), DNA-based bird sex determination across 1,000+ species, and genomic identification of microorganisms and animal species. Service delivery runs through a self-serve client platform (clients.stabvida.com) available in six languages with separate genetics and veterinary portals and is supported by free refrigerated sample collection points at partner institutes.

The business runs a transaction-fee revenue model across catalog services with prepaid EB packages offering up to 20% savings on oligos and sequencing packs; paternity Duo (€260) and Trio (€375) pricing is publicly listed while Sanger, NGS and other specialty services are quote-based. Go-to-market is a hybrid sales-led and self-serve motion: an internal commercial team manages research institutions, universities, hospitals, and biotech accounts across Portugal, Spain, UK, Italy, Brazil, Chile, Uruguay, Angola, and Nigeria; enterprise engagement includes co-development work in FP6/FP7/Horizon 2020 European consortia (EuroGentest, NAD, HILYSENS I/II, LungCard, Extrabrain, DIRNANO, PANA), and consumer testing is sold through the Doctor Vida sub-brand and doctorvida.store.

Beyond the service lab, STAB VIDA has invested in proprietary point-of-care diagnostic devices, including the HILYSENS lab-on-a-chip Lyme disease system (carrying the European Commission Seal of Excellence) and the spinit lab-on-a-disc multiplex isothermal amplification platform for tropical febrile diseases, co-developed with biosurfit and IPATIMUP under FEDER-funded projects (totaling roughly €1.57M in grant financing across spinit-crispr, STAB4COVID, and DV4COVID19). The company is privately held under the GROUP STAB umbrella, with CEO Orfeu Flores also serving as President of GROUP STAB and CEO of STAB SGPS, alongside CIPO/COO Daniela Leão and CSO Sofia Goes.

Name

STAB VIDA

Legal name

STAB VIDA, Lda.

Website

https://stabvida.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

STAB VIDA is a Caparica, Portugal-based ISO-certified genetics laboratory providing Sanger sequencing, NGS, fragment analysis, oligonucleotide synthesis, paternity, clinical, and bird sex DNA testing services to research institutions, hospitals, biotech firms, and consumers across Europe, LATAM, and Africa.

Ownership category

akta.pro rank

Product category

Genetic Testing and DNA Sequencing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• DNA sequencing services
• Genetic testing laboratory
• Oligonucleotide synthesis
• Paternity DNA testing
• Avian sex determination

Headquarters

HQ city

Caparica

HQ country

Portugal

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. DNA Sequencing Services: Sanger sequencing (Premium, You Tube It, Run Only options) and Next Generation Sequencing (plasmid/mitochondrial DNA, whole genome sequencing, RNA sequencing, metagenomics) generate recurring revenue from research institutions and biotech companies. Turnaround times of 24-48h for Sanger and flexible NGS project pricing.
2. Oligonucleotides and PCR Reagents: Sale of standard and premium DNA/RNA oligonucleotides (6-140 bases) and PCR/RT-PCR polymerases (Surf Taq, Surf Hot Taq, Surf Red Taq, Surf Long Taq, Surf PFU, Surf Titan Taq, Surf Titan Hot Taq, Surf Titan H Minus M-MLV RT). Prepaid EB packages offering up to 20% savings and credit purchases across all services.
3. Fragment Analysis and Genotyping: Capillary electrophoresis fragment analysis service using fluorescent probes (Dye Set DS-30 and DS-33) for SNP genotyping, microsatellite detection, and AFLP. Premium and You Plate It service options.
4. Bird Sexing Services: DNA-based bird sex determination using blood, feather, or eggshell samples. Revenue generated per sample with free bird identity card and electronic certificate included. Results in 2-3 working days.
5. Paternity and Clinical Testing: Paternity testing (Duo at €260, Trio at €375) and clinical sequencing including lactose intolerance testing. Legal (Cool Proof) and anonymous test options. Results in 10 working days standard, 2-3 days urgent.
6. Genomic Identification Services: Identification of microorganisms (bacteria, fungi) through 16S and ITS region sequencing, and animal species identification through DNA sequencing, serving veterinary clinics, food industry, and environmental clients.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

STAB VIDA is a Portuguese genetics laboratory that provides DNA sequencing (Sanger and Next Generation), fragment analysis, oligonucleotide synthesis, and PCR reagents to research institutions, universities, hospitals, and biotech companies. The company also offers clinical and consumer-facing genetic tests including paternity testing, lactose intolerance testing, bird sex determination, and genomic identification of microorganisms and animal species, delivered through ISO 9001:2015 and ISO 13485:2018 certified laboratories.

Product overview

STAB VIDA is a genetics laboratory offering a comprehensive portfolio of genetic testing and sequencing services. The core offerings include Sanger Sequencing, Next Generation Sequencing (NGS), Fragment Analysis, and Oligonucleotides/Polymerases for PCR. The company also provides specialized services such as Clinical Sequencing, Paternity Testing, Genomic Identification of Microorganisms or Animal Species, Bird Sex Determination, ELISAs Diagnostics, and Antibodies. Under the Dr Vida sub-brand, the company offers consumer products including Lactose Intolerance Testing and the Doctor Vida Pocket PCR device. The services are delivered through a client platform (clients.stabvida.com) offering separate genetics and bird sexing platforms, with results typically available within 24-48 hours for Sanger sequencing and 2-3 working days for specialized tests.

Differentiator

Problem solved

Functional benefit

Products and services

• Sanger Sequencing Service DNA sequencing service using the Sanger method on ABI 3130 and 3730xl capillary sequencers, offered in three options: Premium (full service with free universal primers and resequencing), You Tube It & You Plate It (client prepares mixture), and Run Only (client prepares reaction with Big Dye). Results delivered in 24-48 hours.
• Next Generation Sequencing (NGS) Massively parallel DNA/RNA sequencing using Ion Torrent, Illumina HiSeq 2500, and MiSeq platforms, supporting whole genome sequencing, plasmid/mitochondrial DNA sequencing, RNA sequencing, and metagenomics/metabarcoding. Includes bioinformatics analysis using CLC Genomics Workbench with up to 1 million reads of 200bp for plasmid coverage.
• Fragment Analysis Capillary electrophoresis fragment analysis using the Hitachi ABI 3730xl platform with Dye Set DS-30 and DS-33 fluorescent probes for SNP genotyping, microsatellite detection, and AFLP. Offered in Premium and You Plate It service options.
• Oligonucleotides and PCR Polymerases Synthesis and sale of standard and premium DNA/RNA oligonucleotides ranging from 6 to 140 bases with various modifications and purifications, plus PCR/RT-PCR polymerases (Surf Taq, Surf Hot Taq, Surf Red Taq, Surf Long Taq, Surf PFU, Surf Titan Taq, Surf Titan Hot Taq, Surf Titan H Minus M-MLV RT). Individual quality verification of all oligos with 48-72 hour delivery. Prepaid EB packages offer up to 20% savings.
• Clinical Sequencing Clinical-grade DNA sequencing services for genetic disease diagnostics and predispositions, using both Sanger and NGS technologies, including Lactose Intolerance Testing as a specific offering. Performed in ISO 13485:2018 certified laboratories.
• Paternity Testing Genetic relationship testing that compares profiles of two or more samples to verify or refute paternal-child connection, analyzing 24 genetic markers (23 STR + Amelogenin) with 99.9999% confidence. Available as Duo (presumed father + 1 child, €260) or Trio (presumed father + child + mother, €375), with both legal (Cool Proof) and anonymous test options. Results in 10 working days standard or 2-3 days urgent.
• Genomic Identification of Microorganisms or Animal Species DNA sequencing-based identification of bacteria, fungi, or animal species through analysis of 16S and ITS regions from isolated samples, colonies, or genetic material. Applications include veterinary clinics, food industry, environmental testing, taxonomy, forensics, archaeology, and ecology.
• Bird Sex Determination DNA-based bird sex determination by detecting Z/W sex chromosomes from blood, feather, or eggshell samples. Method distinguishes males (single band, two Z chromosomes) from females (two bands, Z and W chromosomes). Database of more than 1000 tested bird species. Results in 2-3 working days, with free electronic certificate and bird identity card included.
• ELISAs Diagnostics Enzyme-linked immunosorbent assay (ELISA) diagnostic services for antibody and antigen detection.
• Antibodies Antibody-related products and services for research applications.
• Dr Vida Lactose Intolerance Test Direct-to-consumer genetic test kit for identifying lactose intolerance through analysis of the gene responsible for lactose degradation, marketed under the Dr Vida consumer brand.
• Doctor Vida Pocket PCR Point-of-care portable PCR device marketed under the Doctor Vida brand for research and development applications.

Quantifiable outcome

• 99.9999% confidence for paternity test results using 24 genetic markers (23 STR + Amelogenin)
• +5 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• biosurfit, S.A.coreStrategic or Co-development PartnerCo-promotion partner in the spinit-crispr project (POCI-01-0247-FEDER-033778) for development of a rapid diagnostic test panel for Dengue, Zika and Chikungunya using lab-on-a-disc technology. Total project value €1,364,174.44.
• IPATIMUP – Instituto de Patologia e Imunologia Molecular da Universidade do PortocoreStrategic or Co-development PartnerCo-promotion partner in the spinit-crispr project alongside biosurfit, developing multiplexed molecular isothermal amplification techniques for point-of-care diagnostics.
• Max Planck Institute - MunichminorStrategic or Co-development PartnerAdrian Posado from STAB VIDA performed part of the EXTRABRAIN Project work at Max Planck Institute in Munich, indicating a research collaboration for the FP7 People - Initial Training Network (Grant Agreement No. 606950) focused on extracellular brain proteolysis.
• European Society of Human GeneticsminorOthersCarla Clemente from STAB VIDA participated in the European Society of Human Genetics 2016 conference, maintaining visibility in the clinical genetics community.
• Oxford Nanopore / London Calling ConferenceminorOthersMagdalena Lewicka, STAB VIDA NGS laboratory technician, attended the London Calling 2016 Oxford Nanopore Conference, demonstrating engagement with cutting-edge sequencing technology developments.
• EuroGentest NoE FP6minorStrategic or Co-development PartnerSTAB VIDA participated in EuroGentest Network of Excellence (FP6), which harmonized the entire genetic testing process from sampling to treatment across Europe, contributing to the easyNGS project implementation and coordination of Pulmagene and LungCard FP7 projects.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Eurofins Genomics: One of the largest commercial Sanger/NGS/oligo synthesis service providers globally, with a deep catalog of DNA sequencing, oligonucleotides, and gene synthesis. Directly comparable to STAB VIDA on core Sanger and oligo revenue lines and on multi-platform scale.
• Macrogen: Korean-headquartered global DNA sequencing and NGS services company serving academic and clinical researchers worldwide. Closely overlaps STAB VIDA on Sanger sequencing, NGS, and bioinformatics offerings across a similar research-institution customer base.
• GenScript: Global biotech services provider offering gene synthesis, oligonucleotide synthesis, peptide synthesis, and protein production. Directly competes with STAB VIDA's oligonucleotide and PCR reagent lines and shares the molecular biology services customer profile.
• Fasteris: Swiss DNA sequencing services provider specializing in Sanger, NGS, and oligonucleotide synthesis with academic and applied research customers. Matches STAB VIDA's mid-sized European lab-services profile and its mix of Sanger and NGS offerings.
• Microsynth: Swiss DNA sequencing and oligonucleotide services provider with broad Sanger/NGS offerings to academic and industrial clients. Closely matches STAB VIDA on European-focused research sequencing, custom oligos, and ISO-certified lab operations.
• Source BioScience (Source Genomics): UK-based genomics and diagnostics services company providing sequencing, molecular biology, and clinical laboratory services across Europe. Highly comparable to STAB VIDA's clinical sequencing and paternity testing offerings in the European market.

Others

• bioMérieux: Global in vitro diagnostics company whose molecular biology and infectious disease diagnostics portfolio intersects with STAB VIDA's HILYSENS Lyme and spinit tropical-disease programs. Comparable as a potential commercialization counterpart for STAB VIDA's device-level diagnostic IP.

Broad incumbents

• GeneDx: US-based clinical genomics and genetic testing company offering diagnostic genetic testing at scale across inherited disease, oncology, and rare disease. Adjacent to STAB VIDA's clinical sequencing and paternity testing lines but at significantly larger scale and US footprint.
• LGC Biosearch Technologies: Genomics tools and services arm of LGC Group, offering oligos, qPCR, and sequencing services alongside a much broader life-science measurement portfolio. Comparable to STAB VIDA on oligo/sequencing services and on serving regulated diagnostics customers.

Emerging players

• biosurfit: Portuguese point-of-care diagnostics company and STAB VIDA's co-promoter in the spinit-crispr project. Closely related via the lab-on-a-disc collaboration for Dengue/Zika/Chikungunya PoC testing and overlapping Portuguese medtech ecosystem.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCzSk9-_orAqAyvXeBBwGIrw
• Facebookfacebook.com/StabVida
• LinkedInlinkedin.com/company/stab-vida
• Instagraminstagram.com/stabvida
• Xx.com/STABVIDA

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STAB VIDA